News Search

Columbia University researchers uncovered a signaling pathway in EGFR-mutant lung cancer responsible for driving recurrence and metastases, spreading to the brain.

In a new study, researchers demonstrate that applying artificial intelligence to standard-of-care imaging can help predict how well immunotherapy will work for patients with melanoma.

A clinical trial led by Columbia neuro-oncology team suggests that a new type of anti-cancer drug has promise for patients with glioblastoma.

A new grant from the National Institute of Health will establish a multi-institutional group in New York City to address health disparities in multiple chronic diseases.